DrugPatentWatch Database Preview
Chartwell Rx Company Profile
» See Plans and Pricing
What is the competitive landscape for CHARTWELL RX, and what generic and branded alternatives to CHARTWELL RX drugs are available?
CHARTWELL RX has fifty-nine approved drugs.
Summary for Chartwell Rx
| US Patents: | 0 |
| Tradenames: | 36 |
| Ingredients: | 33 |
| NDAs: | 59 |
Drugs and US Patents for Chartwell Rx
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chartwell Rx | PHENTERMINE HYDROCHLORIDE | phentermine hydrochloride | CAPSULE;ORAL | 088625-001 | Aug 23, 1984 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Rx | NARATRIPTAN | naratriptan hydrochloride | TABLET;ORAL | 090288-001 | Jul 7, 2010 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Rx | RIVASTIGMINE TARTRATE | rivastigmine tartrate | CAPSULE;ORAL | 207797-002 | Sep 28, 2017 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Chartwell Rx | FULVICIN-U/F | griseofulvin, microcrystalline | TABLET;ORAL | 060569-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | Start Trial | Start Trial | |||||
| Chartwell Rx | DUVOID | bethanechol chloride | TABLET;ORAL | 086262-001 | Approved Prior to Jan 1, 1982 | AA | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
